The fusion of echinoderm microtubule-associated protein-like 4 (EML4) and ALK gene by rearrangement in non-small cell lung cancer was identified[9] and developed as a target of the ALK tyrosine kinase inhibitor, crizotinib[10,11]. This evidence concerns the gene EML4 and non-small cell lung carcinoma.